Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

NCT06589609 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Oropharyngeal Squamous Cell Carcinoma (SCC)

Interventions

BIOLOGICAL: FluBHPVE6E7

Sponsor

BlueSky Immunotherapies GmbH